(Q35838299)

10 August 2017

1 reference

title

Cyclophosphamide treatment in systemic necrotizing vasculitis and lupus nephritis. How long? How much? (English)

1 reference

10 August 2017

Beimler JH

1

1 reference

PubMed ID

15257454

10 August 2017

Andrassy K

series ordinal

2

1 reference

10 August 2017

15 July 2004

1 reference

10 August 2017

1 reference

10 August 2017

19

1 reference

10 August 2017

949-955

1 reference

10 August 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1007/s00467-004-1553-6

10 August 2017

0 references

cites work

Treatment of polyarteritis nodosa and microscopic polyangiitis with poor prognosis factors: A prospective trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in sixty-five patients

1 reference

12 December 2020

Long-term followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials including 278 patients

1 reference

12 December 2020

Clinical Pharmacokinetics of Cyclophosphamide

1 reference

12 December 2020

Pneumocystis carinii pneumonia: a major complication of immunosuppressive therapy in patients with Wegener's granulomatosis

1 reference

12 December 2020

Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups

1 reference

12 December 2020

Sequential therapies for proliferative lupus nephritis

1 reference

12 December 2020

Wegener's granulomatosis with renal involvement: patient survival and correlations between initial renal function, renal histology, therapy and renal outcome

1 reference

12 December 2020

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies

1 reference

12 December 2020

Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients

1 reference

12 December 2020

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate

1 reference

12 December 2020

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis

1 reference

12 December 2020

Treatment of good-prognosis polyarteritis nodosa and Churg-Strauss syndrome: comparison of steroids and oral or pulse cyclophosphamide in 25 patients. French Cooperative Study Group for Vasculitides

1 reference

12 December 2020

Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis: initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group

1 reference

12 December 2020

Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

1 reference

12 December 2020

Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens

1 reference

12 December 2020

Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis

1 reference

12 December 2020

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

1 reference

12 December 2020

The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review

1 reference

12 December 2020

Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group

1 reference

12 December 2020

Current Status of Tumor Necrosis Factor Inhibition Strategies in the Treatment of Vasculitis

1 reference

12 December 2020

Wegener's granulomatosis: studies in eighteen patients and a review of the literature

1 reference

12 December 2020

Methylprednisolone and cyclophosphamide, alone or in combination, in patients with lupus nephritis. A randomized, controlled trial

1 reference

12 December 2020

1 reference

12 December 2020

Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide

1 reference

12 December 2020

Wegener Granulomatosis: An Analysis of 158 Patients

1 reference

12 December 2020

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA) A report on the second phase of an international cooperative study on the standardization of ANCA assays

1 reference

12 December 2020

Fertility after treatment for Hodgkin's disease

1 reference

12 December 2020

10.1007/S00467-004-1553-6

Identifiers

DOI

1 reference

10 August 2017

1 reference

PubMed ID

15257454